Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CANOQ NASDAQ:EVGN NASDAQ:FLGC NASDAQ:PULM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCANOQCano Health$0.24$0.24$0.10▼$174.00$1.30MN/AN/AN/AEVGNEvogene$0.53$0.71$0.51▼$1.57$4.58M1.351.47 million shs228,934 shsFLGCFlora Growth$4.04-0.5%$5.19$5.86▼$47.00$4.23M1.939,454 shs6,161 shsPULMPulmatrix$1.46$1.33$1.16▼$9.15$5.33M1.9595,847 shs1.33 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCANOQCano Health0.00%0.00%0.00%0.00%0.00%EVGNEvogene0.00%-10.07%-24.27%-37.93%-66.77%FLGCFlora Growth0.00%-11.40%-3.81%-58.09%-85.57%PULMPulmatrix0.00%+4.29%+6.57%-41.37%-81.47%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCANOQCano Health$0.24$0.24$0.10▼$174.00$1.30MN/AN/AN/AEVGNEvogene$0.53$0.71$0.51▼$1.57$4.58M1.351.47 million shs228,934 shsFLGCFlora Growth$4.04-0.5%$5.19$5.86▼$47.00$4.23M1.939,454 shs6,161 shsPULMPulmatrix$1.46$1.33$1.16▼$9.15$5.33M1.9595,847 shs1.33 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCANOQCano Health0.00%0.00%0.00%0.00%0.00%EVGNEvogene0.00%-10.07%-24.27%-37.93%-66.77%FLGCFlora Growth0.00%-11.40%-3.81%-58.09%-85.57%PULMPulmatrix0.00%+4.29%+6.57%-41.37%-81.47%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCANOQCano Health 0.00N/AN/AN/AEVGNEvogene 2.50Moderate BuyN/AN/AFLGCFlora Growth 2.00Hold$30.00642.57% UpsidePULMPulmatrix 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest CANOQ, PULM, FLGC, and EVGN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/27/2026PULMPulmatrix Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 6/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCANOQCano Health$3.14B0.00N/AN/A($99.38) per share0.00EVGNEvogene$3.85M1.19N/AN/A$1.37 per share0.38FLGCFlora Growth$57.61M0.07N/AN/A$12.21 per share0.33PULMPulmatrix$7.81M0.68N/AN/A$2.45 per share0.60Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCANOQCano Health-$594.42MN/AN/AN/AN/AN/AN/AN/AN/AEVGNEvogene-$8.48M-$1.39N/AN/AN/A-638.12%-158.82%-80.37%8/26/2026 (Estimated)FLGCFlora Growth-$15.91M-$32.49N/AN/AN/A-32.03%-64.02%-34.46%N/APULMPulmatrix-$5.16M-$1.23N/AN/AN/AN/A-107.84%-91.58%8/12/2026 (Estimated)Latest CANOQ, PULM, FLGC, and EVGN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/16/2026Q1 2026EVGNEvogene-$0.27-$0.60-$0.33-$0.60$0.35 million$0.33 million5/15/2026Q1 2026PULMPulmatrixN/A-$0.32N/A-$0.32N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCANOQCano HealthN/AN/AN/AN/AN/AEVGNEvogeneN/AN/AN/AN/AN/AFLGCFlora GrowthN/AN/AN/AN/AN/APULMPulmatrixN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCANOQCano HealthN/AN/AN/AEVGNEvogeneN/A2.792.76FLGCFlora GrowthN/A2.081.79PULMPulmatrixN/A4.964.96Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCANOQCano Health37.97%EVGNEvogene10.40%FLGCFlora Growth36.01%PULMPulmatrix11.84%Insider OwnershipCompanyInsider OwnershipCANOQCano Health13.93%EVGNEvogene7.40%FLGCFlora Growth2.34%PULMPulmatrix0.62%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCANOQCano Health2,7005.41 million4.66 millionN/AEVGNEvogene1408.72 million8.07 millionNo DataFLGCFlora Growth2801.05 million1.02 millionNot OptionablePULMPulmatrix203.65 million3.63 millionNot OptionableCANOQ, PULM, FLGC, and EVGN HeadlinesRecent News About These CompaniesPulmatrix Inc.: Pulmatrix Announces First Quarter 2026 Financial ResultsMay 15, 2026 | finanznachrichten.dePulmatrix Inc : PULMMay 15, 2026 | 247wallst.comPulmatrix Announces First Quarter 2026 Financial ResultsMay 15, 2026 | prnewswire.comPulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned MergerApril 21, 2026 | prnewswire.comPULM Stock Alert: Halper Sadeh LLC is Investigating Whether Pulmatrix, Inc. is Obtaining a Fair Price for its ShareholdersApril 13, 2026 | businesswire.comPulmatrix Inc.: Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve HealthspanMarch 26, 2026 | finanznachrichten.deWave crashes on obesity drug update; Kodiak’s reboot pays dividendsMarch 26, 2026 | biopharmadive.comBPulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapsesMarch 26, 2026 | fiercebiotech.comFPulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve HealthspanMarch 26, 2026 | prnewswire.comCullgen ditches reverse merger with Pulmatrix to go with Gyre in $300M buyoutMarch 2, 2026 | fiercebiotech.comFPulmatrix and Cullgen Terminate Merger AgreementMarch 2, 2026 | contractpharma.comCGyre Therapeutics to Buy Cullgen, Which Ends Merger With PulmatrixMarch 2, 2026 | marketwatch.comPulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger OpportunitiesMarch 2, 2026 | prnewswire.comPulmatrix Inc.: Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial ResultsFebruary 26, 2026 | finanznachrichten.dePulmatrix Announces Year-End and Fourth Quarter 2025 Financial ResultsFebruary 26, 2026 | prnewswire.comGNI subsidiary Cullgen and Pulmatrix relax merger terms to seek strategic alternativesDecember 19, 2025 | msn.comPulmatrix and Cullgen continue to pursue mergerDecember 18, 2025 | msn.comPulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore AlternativesDecember 18, 2025 | prnewswire.comPulmatrix Reports Q3 2025 Results and Strategic ShiftOctober 16, 2025 | tipranks.comPulmatrix reports Q3 EPS (24c) vs. (71c) last yearOctober 16, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCANOQ, PULM, FLGC, and EVGN Company DescriptionsCano Health NYSE:CANOQCano Health, Inc. provides primary care medical services to its members in Florida, the United States. It offers health care plans for seniors through Medicare Advantage program that allows members to get access to its affiliated medical centers providers and physicians to set appointments, and administers integrated virtual care, wellness services, ancillary services, such as physiotherapy, home services, transportation, telemedicine, and a 24/7 urgency line without any additional costs. The company operates pharmacies, as well as provides dental and pharmacy delivery services. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida. On February 4, 2024, Cano Health, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.Evogene NASDAQ:EVGN$0.53 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$0.53 +0.01 (+1.12%) As of 06/18/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.Flora Growth NASDAQ:FLGC$4.04 -0.02 (-0.49%) As of 06/18/2026Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.Pulmatrix NASDAQ:PULM$1.46 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.52 +0.06 (+4.45%) As of 06/18/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/15 - 06/19 Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself? Why Kroger’s Pullback Could Be a Gift for Patient Investors Credo Technologies Accelerates AI—Its Stock Price Will Follow Why Rocket Lab’s Nasdaq-100 Moment Could Change the Story Why Palantir’s Google Cloud Deal Could Change the Debate VMware: Broadcom's Second Biggest Business Set to Accelerate Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
